{
  "resourceType" : "CodeSystem",
  "id" : "cs-senologie-genexpressionstest",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cs-senologie-genexpressionstest</b></p><a name=\"cs-senologie-genexpressionstest\"> </a><a name=\"hccs-senologie-genexpressionstest\"> </a><p>This case-sensitive code system <code>https://www.senologie.org/fhir/CodeSystem/cs-senologie-genexpressionstest</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">oncotype-dx<a name=\"cs-senologie-genexpressionstest-oncotype-dx\"> </a></td><td>Oncotype DX</td><td>21-Gen Recurrence Score Assay (Exact Sciences). Score 0–100.</td></tr><tr><td style=\"white-space:nowrap\">mammaprint<a name=\"cs-senologie-genexpressionstest-mammaprint\"> </a></td><td>MammaPrint</td><td>70-Gen Signatur (Agendia). Index -1.0 bis +1.0.</td></tr><tr><td style=\"white-space:nowrap\">prosigna<a name=\"cs-senologie-genexpressionstest-prosigna\"> </a></td><td>Prosigna (PAM50)</td><td>50-Gen ROR Score Assay (Veracyte). Score 0–100.</td></tr><tr><td style=\"white-space:nowrap\">endopredict<a name=\"cs-senologie-genexpressionstest-endopredict\"> </a></td><td>EndoPredict</td><td>12-Gen EPclin Score (Myriad Genetics). Kontinuierlicher Score.</td></tr></table></div>"
  },
  "url" : "https://www.senologie.org/fhir/CodeSystem/cs-senologie-genexpressionstest",
  "version" : "0.9.0",
  "name" : "CS_Senologie_Genexpressionstest",
  "title" : "CS Senologie Genexpressionstest",
  "status" : "draft",
  "date" : "2026-05-04T16:55:55+00:00",
  "publisher" : "Berlin Institute of Health at Charité (BIH)",
  "contact" : [{
    "name" : "Berlin Institute of Health at Charité (BIH)",
    "telecom" : [{
      "system" : "url",
      "value" : "https://www.bihealth.org"
    }]
  }],
  "description" : "Genexpressionstests zur Abschätzung des Rezidivrisikos bei Mammakarzinom",
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 4,
  "concept" : [{
    "code" : "oncotype-dx",
    "display" : "Oncotype DX",
    "definition" : "21-Gen Recurrence Score Assay (Exact Sciences). Score 0–100."
  },
  {
    "code" : "mammaprint",
    "display" : "MammaPrint",
    "definition" : "70-Gen Signatur (Agendia). Index -1.0 bis +1.0."
  },
  {
    "code" : "prosigna",
    "display" : "Prosigna (PAM50)",
    "definition" : "50-Gen ROR Score Assay (Veracyte). Score 0–100."
  },
  {
    "code" : "endopredict",
    "display" : "EndoPredict",
    "definition" : "12-Gen EPclin Score (Myriad Genetics). Kontinuierlicher Score."
  }]
}